Fig. 6From: CD11c-specific bio-nanocapsule enhances vaccine immunogenicity by targeting immune cellsInduction of OVA-specific IgGs production with α-DC-ZZ-BNC-OVA. Mice received subcutaneous injection of α-DC-ZZ-BNC-OVA. Sera were collected from the immunized mice, and then titers of OVA-specific IgG1 (a) and IgG2a (b) in sera were determined by ELISA (N = 6, mean ± SEM)Back to article page